Terms: = Leukemia AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
8 results:
1. Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic leukemia.
Tomic Vujovic K; Ugrin M; Tosic N; Vukovic V; Marjanovic I; Kostic T; Stankovic S; Otasevic V; Sarac S; Antic D; Pavlovic S; Karan-Djurasevic T
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255996
[TBL] [Abstract] [Full Text] [Related]
2. malat1 expression is associated with aggressive behavior in indolent B-cell neoplasms.
Fernández-Garnacho EM; Nadeu F; Martín S; Mozas P; Rivero A; Delgado J; Giné E; López-Guillermo A; Duran-Ferrer M; Salaverria I; López C; Beà S; Demajo S; Jares P; Puente XS; Martín-Subero JI; Campo E; Hernández L
Sci Rep; 2023 Oct; 13(1):16839. PubMed ID: 37803049
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of LncRNA-malat1 in Peripheral Blood of Patients with Acute Myeloid leukemia Sepsis and Its Clinical Significance].
Zeng SY; Lyu M; Yuan J; Hu YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1763-1767. PubMed ID: 34893107
[TBL] [Abstract] [Full Text] [Related]
4. Systematic analysis reveals a lncRNA-miRNA-mRNA network associated with dasatinib resistance in chronic myeloid leukemia.
Luo J; Gao Y; Lin X; Guan X
Ann Palliat Med; 2021 Feb; 10(2):1727-1738. PubMed ID: 33302634
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA-malat1 regulates proliferation and apoptosis of acute lymphoblastic leukemia cells via miR-205-PTK7 pathway.
Song Y; Guo NH; Zheng JF
Pathol Int; 2020 Oct; 70(10):724-732. PubMed ID: 32754978
[TBL] [Abstract] [Full Text] [Related]
6. Transcript-level regulation of malat1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the malat1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.
Hu Y; Lin J; Fang H; Fang J; Li C; Chen W; Liu S; Ondrejka S; Gong Z; Reu F; Maciejewski J; Yi Q; Zhao JJ
Leukemia; 2018 Oct; 32(10):2250-2262. PubMed ID: 29632340
[TBL] [Abstract] [Full Text] [Related]
8. Drugging the lncRNA malat1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.
Amodio N; Stamato MA; Juli G; Morelli E; Fulciniti M; Manzoni M; Taiana E; Agnelli L; Cantafio MEG; Romeo E; Raimondi L; Caracciolo D; Zuccalà V; Rossi M; Neri A; Munshi NC; Tagliaferri P; Tassone P
Leukemia; 2018 Sep; 32(9):1948-1957. PubMed ID: 29487387
[TBL] [Abstract] [Full Text] [Related]
